| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482267C Preparation for diabetes and its making method |
| 04/29/2009 | CN100482245C Medicine composition contg. isatis root and scutellariae glucoside |
| 04/29/2009 | CN100482244C Compound recipe medicine for treating apoplexy and its preparation method |
| 04/29/2009 | CN100482238C Cosmetics |
| 04/29/2009 | CN100482237C Polysaccharid glucoside Chinese medicinal oral preparation and its making method thereof |
| 04/29/2009 | CN100482236C Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
| 04/29/2009 | CN100482235C 2-glucoside Chinese medicinal oral preparation and its making method thereof |
| 04/29/2009 | CN100482234C Stibene-glucoside oral liquid and its production method |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482232C Powder medicine suitable for human and animal trauma |
| 04/29/2009 | CN100482231C Cefepime hydrochloride powder injection and preparing method thereof |
| 04/29/2009 | CN100482230C Method for preparing minoxidil tincture |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/29/2009 | CN100482228C Biologic skin repair and enhancement |
| 04/29/2009 | CN100482227C Sustained release compound capsules and its preparation method |
| 04/29/2009 | CN100482226C Composition for covering flavor and preparation of containing the composition |
| 04/29/2009 | CN100482225C Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/29/2009 | CN100482224C Composite medicine for treating tumor and its application |
| 04/29/2009 | CN100482223C 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors |
| 04/29/2009 | CN100482222C Usage of 1H-indole-2, 3-diketone and its derivant in the process for preparing anemia treating medicine and medicine for treating anemia |
| 04/29/2009 | CN100482221C Use of nefopam for the treatment of nausea or emesis |
| 04/29/2009 | CN100482220C Oral preparation of bilobalide with high bioavailability and preparation method thereof |
| 04/29/2009 | CN100482219C Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 04/29/2009 | CN100482218C Application of Danshensu in preparation of medicine for treating cerebrovascular diseases |
| 04/29/2009 | CN100482217C Medical usage of 2beta-hydroxyilicicacid in inhibiting hepatitis B |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482211C Medicinal targeted local lipolysis |
| 04/29/2009 | CN100482210C External applied Chinese medicinal paste for treating arthralgia |
| 04/29/2009 | CN100482208C Compound licorice medicine prepn and its prepn process |
| 04/29/2009 | CN100482112C Traditional Chinese medicine additive for cigarette, its prepn. method and quality control method |
| 04/29/2009 | CN100482095C Injure preventing agent for forcedly changing feather and method for forcedly changing feather |
| 04/29/2009 | CN100482087C Method for preparing compound micrometer radix pseudostellariae sugar reducing and calcium supplementing bean milk powder |
| 04/29/2009 | CN100482086C Method for preparing micrometer sugared western and Chinese ginseng and wolfberry essence, bee glue, chromium yin nourishing and sugar reducing milk powder |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7525011 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 04/28/2009 | US7524980 Vitamin D3 lactam derivative |
| 04/28/2009 | US7524975 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 04/28/2009 | US7524973 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524965 Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2009 | US7524962 Biphenyl compounds useful as muscarinic receptor antagonists |
| 04/28/2009 | US7524960 Reacting 6-hydroxy-3,4-dihydroquinolin-2(1H)-one with 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in the presence of a hydrated inorganic base; free of N-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; purity of at least 99.9%. |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524958 Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524956 Hemisynthetic method and new compounds |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524938 using a hapten comprising tetracarboxy phenyl porphyrin zinc or cobalt complexes, to generate monoclonal or polyclonal antibodies and testing for inhibitory effects of the antibodies on the gelatinase B; metalloenzyme inhibitors |
| 04/28/2009 | US7524887 use of 2-(phenylalkyl)-substituted 2-amino-1,3-propanediols such as 2-amino-2-[2-(4-heptylphenyl)ethyl]-1,3-propanediol to treat chronic pain such as that associated with AIDs, chemotherapy, tumors, back pain; sphingosine-1-phosphate (SIP)-receptor agonists |
| 04/28/2009 | US7524886 L-(−)-moprolol L-(+)-tartrate |
| 04/28/2009 | US7524885 cyclopropane or cyclobutane carboxylic acid esters, amides or thioesters; ischemic/reperfusion injury, myocardial ischemia; bioavailability, high half-life in vivo; Pyruvate Dehydrogenase Kinase (PDHK) inhibitors; e.g. cyclopropanecarboxylic acid, 2-(2-cyclopropanecarbonyloxy-ethoxy)-ethyl ester |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524882 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/28/2009 | US7524881 High purity material from reverse phase column chromatography separation |
| 04/28/2009 | US7524880 Napadisylate salt formation of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide in an aqueous isopropanol or ethanol solution; chronic obstructive pulmonary disorder, asthma; muscarinic receptor antagonists |
| 04/28/2009 | US7524879 Ion channel modulating compounds and uses thereof |
| 04/28/2009 | US7524878 Phenyl substituted carboxylic acids |
| 04/28/2009 | US7524877 Compounds for use in weight loss and appetite suppression in humans |
| 04/28/2009 | US7524876 Luciferin derivatives |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524872 Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524870 3-(3'-Acetylamino-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity |
| 04/28/2009 | US7524869 Taxanes having a C10 ester substituent |
| 04/28/2009 | US7524868 Cannabinoid 1 receptor antagonists, high binding affinity; N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H -pyrazole-3-carboxamide; bulimia, obesity, non-insulin-dependent diabetes |
| 04/28/2009 | US7524867 Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity |
| 04/28/2009 | US7524866 Prevention and treatment of androgen—deprivation induced osteoporosis |
| 04/28/2009 | US7524865 Methods and compositions for treating an ocular neovascular disease |
| 04/28/2009 | US7524864 Methods of treating sleep disorders |
| 04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| 04/28/2009 | US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524860 Antibacterial agents |
| 04/28/2009 | US7524859 Treating hyperproliferative disorders such as gastrointestinal cancer, breast cancer, head cancer, or neck cancer; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524857 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 04/28/2009 | US7524856 Tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2009 | US7524855 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae) |
| 04/28/2009 | US7524854 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524851 Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy |
| 04/28/2009 | US7524850 1-{1-[4-(6-hydroxy-5-isobutyl-3-phenylpyrazin-2-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; serine/threonine protein kinase; antiproliferative |
| 04/28/2009 | US7524849 5-arylpyrimidines as anticancer agents |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524845 Chemokine receptor 1 (CCR1) antagonists; 1-[4-phenylpiperazin-1-yl]-2-pyrazolo[4,3-b]pyridin-1-yl-ethanone compounds; inflammatory condition or autoimmune disorders such as rheumatoid arthritis, multiple sclerosis, transplant rejection, restenosis, dermatitis |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524842 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524840 Inhibit angiogenesis, kinase activity; cancer tumors; convert a benzodiazepine lactam to an O-methyl ether; react ether with dimethyl acetal of N,N-dimethyl acetamide; react with hydrazine; 5-(2-chlorophenyl)-1,2-dihydro-7-fluoro-8-(3-(4-morpholinyl)propoxy))-3-methyl-pyrazolo[3,4-b][1,4]benzodiazepine |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | US7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |